✦ LIBER ✦

Pharmacokinetics and pharmacodynamics of the ACAT inhibitor DuP128 in man

✍ Scribed by C.M. Lai; B.L. Brogdon; H.J. Pieniaszek; C.Y. Quon; H. Zyruk; J.M. Connell; I.H. Benedek; J.W. Hainer; J.G. Terry; J.R. Crouse III

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acyl CoA:cholesterol acyltransferase (AC

✍ Richard G. Wilde; John D. Klaczkiewicz; Jeffrey T. Billheimer; Ruth R. Wexler; P 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Pharmacokinetics and pharmacodynamics of

✍ P. D. Whiteman; A. S. E. Fowle; M. J. Hamilton; A. W. Peck; A. Bye; K. Dean; A. 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 652 KB

Pharmacokinetics and pharmacodynamics of

✍ John L Reid; Peter A Meredith; Henry L Elliott 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 681 KB

The α-glucosidase inhibitor voglibose (A

✍ H. Fuder; P. Kleist; M. Birkel; A. Ehrlich; S. Emeklibas; W. Maslak; E. Stridde; 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 195 KB

Pharmacokinetics/Pharmacodynamics of Y-7

✍ I. Yamada; A. Fukunari; T. Osajima; M. Kamezawa; H. Mori; J. Iwane 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 8 KB

## Abstract For Abstract see ChemInform Abstract in Full Text.

Pharmacokinetics/Pharmacodynamics of Y‐7

✍ Yamada †, I.; Fukunari †, A.; Osajima, T.; Kamezawa, M.; Mori, H.; Iwane, J. 📂 Article 📅 2004 🏛 Taylor and Francis Group 🌐 English ⚖ 90 KB